Table 3.
Immune Function by HSCT in All Unvaccinated Participants
| HSCT=No (N=23) | HSCT=Yes (N=16) | p | |
|---|---|---|---|
|
| |||
| Immune Function | N (%) | N (%) | |
| Total B Cell percent (%) | 0.22 | ||
| Low | 5 (33%) | 2 (13%) | |
| Normal/High | 10 (67%) | 14 (88%) | |
| Total Memory B Cell percent (%) | 0.60 | ||
| Low | 1 (7%) | 3 (19%) | |
| Normal/High | 13 (93%) | 13 (81%) | |
| CD4 Absolute | 0.56 | ||
| Low | 1 (4%) | 2 (13%) | |
| Normal/High | 22 (96%) | 14 (88%) | |
| IgG (mg/dL) | 0.72 | ||
| Low | 5 (24%) | 5 (31%) | |
| Normal/High | 16 (76%) | 11 (69%) | |
| Diphtheria (IU/mL) | 1.00 | ||
| Negative | 1 (5%) | 1 (6%) | |
| Positive | 21 (95%) | 15 (94%) | |
| Tetanus (IU/mL) | - | ||
| Negative | - | - | |
| Positive | 22 (100%) | 16 (100%) | |
Note: Data are shown as frequency (%) and compared using Fisher’s exact test. HSCT, hematopoietic stem cell transplant. IU, international units. Tetanus and diphtheria vaccinations were only included if they were given post-HSCT.